Question 1

How do I prove ROI from investing in medical device usability research?

Accepted Answer

ROI from medical device usability research becomes evident when you show how it prevented costly issues and improved product success. If early usability tests caught design flaws or user errors that would have led to expensive fixes, regulatory setbacks, or even safety risks, quantify those averted costs as returns on the research investment. Also, link the research to positive outcomes: for instance, a device refined via usability feedback might see higher adoption by clinicians or patients, leading to better sales or fewer support calls. Medical device firms often face strict FDA human factors requirements, so meeting those smoothly thanks to good research avoids delays — that time and expense saved is part of the ROI story as well. By compiling these proof points (costs avoided, faster approvals, improved user satisfaction), you make a compelling case for the value generated by the usability studies.

Question 2

What ethical considerations apply when observing participants?

Accepted Answer

Ethical considerations when observing participants include obtaining informed consent (whenever practical), protecting their privacy, and minimizing your influence on their behavior. In controlled settings like a lab or scheduled home visit, participants should know they're being observed and agree to it. In public spaces where direct consent isn't feasible, stick to observing what is clearly public and avoid collecting any personal identifiers. Privacy is crucial: only record what's necessary, secure any footage or notes, and anonymize personal details in your analysis and reporting. Observers must also remain as unobtrusive as possible, refraining from interaction or interference so as not to alter the participants' natural behavior. If participants are aware of the observation, remind them they can pause or withdraw at any time if they feel uncomfortable. Ultimately, treat individuals with respect and confidentiality — ensure your observation doesn't harm or embarrass anyone and that data is handled with care.

Question 3

When should local qual be used to resolve conflicting global quant signals?

Accepted Answer

You should turn to local qualitative research when your global quantitative data shows puzzling or conflicting results that you can't fully explain with numbers alone. If a global survey or dataset has outliers or opposite trends in specific markets (for instance, one country's satisfaction scores dropped while others rose), it's a sign that local context needs to be explored qualitatively. In such cases, conducting focus groups or in-depth interviews in the particular region helps uncover cultural nuances or specific issues behind the anomaly. Local qual is also useful when stakeholders are unsure why a metric is underperforming in one area despite overall positive global averages. By hearing directly from local customers or employees, researchers can find the "why" that the spreadsheet data is missing. In summary, whenever the what of the data (the numbers) doesn't line up across regions, local qual should be deployed to clarify the why.

Question 4

What permissions do I need to record and transcribe focus group sessions?

Accepted Answer

You should obtain explicit consent from participants before recording any focus group session or creating transcripts. Typically this means having each participant sign a consent form (or agree via a digital form) that clearly states the discussion will be audio/video recorded and later transcribed. The consent should cover how the recordings and transcripts will be used, stored, and shared. In many jurisdictions it's a legal requirement that all parties are aware of and agree to being recorded (so-called "two-party consent"). Additionally, if the focus group is being held in a rented facility, ensure the venue allows recording. By securing written permission from participants and meeting any local privacy laws (for example, GDPR in Europe), you protect both the participants' rights and your organization from legal issues.

Question 5

How do we measure the impact of stronger AI governance on risk?

Accepted Answer

Measure the impact of stronger AI governance on risk by tracking key risk indicators before and after the governance improvements and noting any reductions in negative outcomes. Start by defining metrics that reflect AI-related risk, such as the number of AI incidents (e.g. erroneous decisions, compliance breaches, or near-misses) or the percentage of models passing bias and fairness checks. If stronger governance is effective, you should see those metrics improve over time — like fewer incidents or higher compliance rates. For example, if prior to new governance policies the organization logged several AI output errors or customer complaints per quarter, and after implementing stricter review, monitoring, and accountability frameworks that drops to near zero, that's tangible evidence of risk reduction. You can also quantify risk by assessing potential financial or reputational damage avoided: if a robust AI oversight prevented a likely costly failure, estimate the value of that averted loss. In short, demonstrating ROI here means linking governance measures to concrete declines in risk metrics and showing how those declines protect or enhance the business (fewer fines, better decision outcomes, preserved trust).

Robas Research

Why choose Us

Features and attributes

What is Robas Research?

Robas Research Recognition & Certifications

Robas Research Services and Expertise

Market Research FAQs with Expert Insights

How do I prove ROI from investing in medical device usability research?

What ethical considerations apply when observing participants?

When should local qual be used to resolve conflicting global quant signals?

What permissions do I need to record and transcribe focus group sessions?

How do we measure the impact of stronger AI governance on risk?